Anti-inflammatory drug does not reduce risk of major CV events following heart attack
Michelle L. O'Donoghue, M.D., M.P.H., of Brigham and Women's Hospital, Boston, and colleagues evaluated the efficacy and safety of the anti-inflammatory drug losmapimod on cardiovascular outcomes in patients hospitalized ...
Apr 4, 2016
0
0